142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

302185
Justification for mandating annual influenza vaccination

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014

Marc D. Hiller, MPH, DrPH , Department of Health Management and Policy, University of New Hampshire, Durham, NH
Dora Anne Mills, MD, MPH, FAAP , University of New England, Portland, ME
Influenza and pneumonia are the 8th leading causes of death in the United States, with influenza causing an average of 23,600 deaths annually. Deaths from influenza often exceed those from motor vehicle crashes. What is especially tragic is that much of the impact from influenza is preventable. It is estimated that even with influenza vaccine rates of under 50%, during the 2012-2013 influenza season, vaccine resulted in 79,000 (17%) fewer hospitalizations and averted 6.6 million illnesses and 3.2 million medically attended illnesses due to influenza.

Since 2010 public health authorities have recommended universal vaccine against influenza for those 6 months and older. While vaccine rates have risen, they remain at overall low rates of 50% or under. Even among health care workers, rates are about 72%, despite educational efforts. 

While immunizations against influenza like other preventable diseases, provide necessary primary prevention for individuals, stronger efforts to increase vaccine rates to achieve levels that at least offer herd immunity is important for the public’s well-being and improving the health status of populations, as well as for reducing lost productivity and rising health care costs. Simply put, influenza prevention is simply cost effective on multiple fronts for both individuals and communities.

Given the tragic annual impact of influenza, the authors recommend mandated annual influenza vaccine, especially in schools and colleges, health care settings, and many workplaces, where disease transmission impacts large population groups, many of whom may often face higher risks, suffer from compromised immune systems, or have other illnesses. Such requirements should come from the private sector as well as the public sector. Rates are higher when vaccines are mandated. For instance, rates among health care workers rise to 97% when employers mandate its use. And, such vaccination, even among healthy populations, saves lives. Mandates should provide for reasonable exceptions such as for medical and religious reasons.

The authors analyze and provide ethical, legal, and public health reasons to justify these strategies, and use the effectiveness of other mandated vaccines and public health interventions as models. While mandating vaccinations may be viewed by some as limiting individual liberties, assuring it reduces health disparities and promotes social justice, beyond simply reflecting sound public health practice.

Learning Areas:

Ethics, professional and legal requirements
Occupational health and safety
Protection of the public in relation to communicable diseases including prevention or control
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy

Learning Objectives:
Describe the ethical, legal, and public health basis for mandating annual influenza vaccinations. Describe the significance and risks of not imposing universal influenza vaccinations. Discuss how mandating influenza vaccinations among major segments of the population reduces health disparity and promotes social justice.

Keyword(s): Immunizations, Public Health Policy

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Professor of Health Management and Policy and Coordinator of Undergraduate Public Health Option, College of Health and Human Services, University of New Hampshire (34 years); national leader in APHA (Chair, CoA; Action Board; Executive Board Committee on Social Responsibility); Founder and Past President, NH Public Health Association (past Board Member for 10 years); SOPHE (Co-Chair Ethics Committee); NALBOH (national advisory committee). Professor; well-published researcher/scholar; nationally noted expert in public health ethics, public health activist
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.